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Abstract
Background: Adverse Reaction to Metal Debris (ARMD) is a major reason for revision surgeries in patients
with metal-on-metal (MoM) hip replacements. Most failures are related to excessively wearing implant
producing harmful metal debris (extrinsic factor). As ARMD may also occur in patients with low-wearing
implants, it has been suggested that there are differences in host-specific intrinsic factors contributing to
the development of ARMD. However, there are no studies that have directly assessed whether the development of
ARMD is actually affected by these intrinsic factors.
Methods: We included all 29 patients (out of 33 patients) with sufficient data who had undergone bilateral revision of
ASR MoM hips (58 hips) at our institution. Samples of the inflamed synovia and/or pseudotumour were obtained
perioperatively and sent to histopathological analysis. Total wear volumes of the implants were assessed. Patients
underwent MARS-MRI imaging of the hips preoperatively. Histological findings, imaging findings and total wear
volumes between the hips of each patient were compared.
Results: The difference in wear volume between the hips was clinically and statistically significant (median difference
15.35mm3, range 1 to 39mm3, IQR 6 to 23mm3) (p < 0.001). The median ratio of total wear volume between the hips
was 2.0 (range 1.09 to 10.0, IQR 1.67 to 3.72). In majority of the histological features and in presence of pseudotumour,
there were no differences between the left and right hip of each patient (p > 0.05 for all comparisons). These features
included macrophage sheet thickness, perivascular lymphocyte cuff thickness, presence of plasma cells, presence of
diffuse lymphocytic infiltration and presence of germinal centers.
Conclusions: Despite the significantly differing amounts of wear (extrinsic factor) seen between the sides, majority of
the histological findings were similar in both hips and the presence of pseudotumour was symmetrical in most hips. As
a direct consequence, it follows that there must be intrinsic factors which contribute to the symmetry of the findings,
ie. the pathogenesis of ARMD, on individual level. This has been hypothesized in the literature but no studies have
been conducted to confirm the hypothesis. Further, as the threshold of metal debris needed to develop ARMD appears
to be largely variable based on the previous literature, it is likely that there are between-patient differences in
these intrinsic factors, ie. the host response to metal debris is individual.
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Background
Adverse Reaction to Metal Debris (ARMD) continues to
be a major reason for revision surgeries in patients with
Metal-on-Metal (MoM) hip replacements [1, 2]. ARMD
consists of very variable and heterogenous findings and
symptoms. Patients may experience strong pain and dis-
comfort or be completely asymptomatic [3]. Radiologically,
fluid-filled cystic lesions or solid inflammatory soft-tissue
masses termed pseudotumors can be found on some pa-
tients, both symptomatic and asymptomatic [4, 5]. Micro-
scopical findings in periprosthetic tissue range from mild
macrophage infiltration to deep soft-tissue necrosis with
heavy lymphocyte infiltration [6–8]. In summary, there is a
high between-subject variability with regard to symptoms,
clinical findings and histological presentation of the tissues
in patients with ARMD.
Factors that affect the development of ARMD can be
divided into extrinsic and intrinsic. The amount of wear
debris and physicochemical properties of the particles
are examples of extrinsic factors. Intrinsic factors, such
as individual differences in innate and adaptive immune
responses to metal wear debris, can be collectively re-
ferred to as host response [9]. Several retrieval studies
have investigated extrinsic factors, most importantly
implant wear, and their association to ARMD. Many
studies have shown that implant wear is a risk factor for
the development of ARMD [10–12]. However, adverse
reactions have also been observed in patients with low
wearing hip implants in several studies [8, 13–15]. In
their systematic review, Campbell et al. concluded that
no clear dose-response relationship between wear and
ARMD could be established due to the heterogeneity of
the findings in the included studies [16]. Studies that have
investigated association between the histopathological fea-
tures of ARMD and wear or indirect markers of wear, such
as synovial fluid or whole blood metal ion concentrations,
have also yielded inconsistent results [6, 8, 14, 17–23]. The
lack of a clear association between extrinsic factors and the
development of ARMD could be due to a remarkable role
of intrinsic factors affecting the pathogenesis. In fact, the
contribution of host-specific factors and presence of pa-
tient susceptibility has been suggested in numerous previ-
ous studies based on the between-subject discrepancy in
the amount of wear debris needed to result in ARMD and
implant failure [8, 13, 14, 24–28]. Further, it has been
suggested that women are more susceptible than men,
possibly due to previous exposure to metals from jewelry
[14, 15, 29]. However, to the best of our knowledge, there
are no studies that would have actually investigated
whether intrinsic factors affect the pathogenesis of ARMD
in patients with MoM hips.
In the present study, we aimed to indirectly investigate
whether host-specific intrinsic factors affecting the
pathogenesis of ARMD exist in a cohort of patients with
bilateral ASR hips, both of which were revised for
ARMD. Host response was investigated by comparing
both histological findings and the amount of bearing
surface wear volume (extrinsic factor) between each
patient’s left and right hips. Each hip served as a control
for the other. If the tissue response between the hips
was similar (low within-subject variability) despite differ-
ing amount of wear debris between the sides (difference
in an extrinsic factor), it would indicate the presence of
intrinsic factors contributing to the similarity of the tissue
response (Additional file 1). We had three hypotheses: 1)
there is significant congruence in histological findings
between the hips of each patient (low within-subject vari-
ability) despite differing amount of wear between the hips,
indicating the contribution of intrinsic factors in the
pathogenesis, 2) histological findings characteristic of the
innate immune response or direct cytotoxic effects of
metal debris (macrophages, granulomas and necrosis)
would differ between the sides in response to wear debris
and 3) components of the individual adaptive immune
response (lymphocytes, germinal centers and plasma cells)
would be congruent between the sides as a result of con-
tribution of intrinsic factors.
Methods
Study design
One thousand thirty-six Articular Surface Replacement
(ASR) MoM hip replacements (Depuy Orthopaedics,
Warsaw, IN, USA) were performed in 887 patients at
our institution between March 2004 and December
2009. By the end of September 2016, 316 patients had
been revised. Of these, 33 patients have undergone bilat-
eral revision. Four of these patients were excluded due to
missing tissue samples thus leading to 29 patients being
included in our study (58 hips). Flow chart of the patient
selection is available as a supplement (Additional file 2).
All patients had the same head-cup-combination on both
sides: five patients had bilateral ASR hip resurfacing and
24 patients had ASR XL stemmed total hip replacements
bilaterally. Simultaneous bilateral hip revision was per-
formed for two patients, and the remaining 27 patients’
bilateral revision surgeries were performed sequentially.
Revision operations have been described in detail in our
previous publication [30]. Patient demographics and indi-
cations for revision surgery are presented in Table 1.
Surgery was performed by or under the direct supervision
of 10 senior orthopedic surgeons. All patients gave written
informed consent to participate in this study that was ap-
proved by the ethical committee of Pirkanmaa Hospital
District (R11006).
Follow-up
After the recall of DePuy ASR hip arthroplasties and the
Medicines and Healthcare products Regulatory Agency
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(MHRA) medical device alert regarding MoM hip
arthroplasties, a systematic screening programme was
launched at our institution [31, 32]. All patients with
MoM hip arthroplasty were included in the programme.
Patients were given Oxford Hip Score questionnaire,
examined physically (including the Harris Hip Score)
and whole blood chromium and cobalt ion levels were
measured [33, 34]. Hip and pelvic radiographs were
taken before each visit. In addition, all patients were
referred for Metal Artifact Reduction Sequence MRI
(MARS-MRI), unless there were contraindications, in
which case patients were referred for ultrasound imaging
of the hips. Findings were classified using a previously
published pseudotumour classification [4]. For the
purposes of the study, pseudotumours were considered
as fluid-filled or solid soft-tissue masses adjacent to the
articulation (classes 1, 2A, 2B or 3).
Indications for revision surgery
Revision surgery was considered if 1) a clear pseudotumour
(class 2A,2B or 3) [4] was observed on cross-sectional im-
aging regardless of symptoms or whole blood (WB) metal
ion levels; or 2) the patient had elevated WB metal ion
levels and hip symptoms despite normal findings in
cross-sectional imaging; or 3) the patient had a continu-
ously symptomatic hip or progressive symptoms regardless
of imaging findings or metal ion levels; or 4) the patient
had progressively increasing blood metal ion levels, even
without symptoms or findings in cross-sectional imaging.
Symptoms included hip pain, discomfort, sense of instabil-
ity, and/or impaired function of the hip and sounds from
the hip (clacking, squeaking). WB metal ion levels were
regarded as being elevated if either chromium or cobalt
exceeded 5 ppb [35].
Bearing wear analysis
The volume of material loss from the cup and head
bearing surfaces was measured using a Zeiss Prismo
(Carl Zeiss Ltd., Rugby, UK) coordinate measuring ma-
chine (CMM). A total of 400 polar scan lines on each
surface were defined and up to 30,000 data points cap-
tured using a 2 mm ruby stylus; protocols for this
method have been previously published [36]. An iterative
least square fitting method was used to analyze the raw
data captured by the CMM and the unworn geometry of
the bearing surface was used to map regions of material
loss from which the total volumetric loss was calculated
for each component. Total wear volume was calculated by
combining head and cup wear volumes for each patient.
Histopathological analysis of the periprosthetic tissue
During every hip revision, samples of the inflamed synovia
or pseudotumor capsule were obtained. For histopatho-
logical analysis, each tissue sample was formalin fixed and
embedded in paraffin. Several 10 μm microtome sections
were made and stained with standard hematoxylin and
eosin staining. The sections were examined histologically
under transmitted light with a Nikon Eclipse 50i micro-
scope (Nikon Corporation, Shinagawa, Tokyo, Japan). The
sections were graded by a senior musculoskeletal patholo-
gist (JP) using scoring principles adopted from the study
by Natu et al. [7]. The pathologist was blinded from clin-
ical patient characteristics.
The Natu grading consisted of following parameters:
1) macrophage sheet thickness, 2) lymphocyte cuff thick-
ness, 3) degree of necrosis, 4) presence of plasma cells,
5) presence of diffuse lymphocytic infiltrate, 6) presence
of germinal centers, and 7) presence of granulomas.
Thickness of histiocyte sheets was calculated using a
graticule and graded 0–3 (absent, < 1 mm, 1–2 mm, > 2
mm). Lymphocyte cuff thickness was also calculated
using a graticule. An average of five measurements was
taken and graded as 0–3 (absent, 0.25 mm, 0.25–0.75
mm, > 0.75 mm). The extent of overall tissue necrosis in
a sample was graded based on the surface necrosis typ-
ing according to Davies et al. [37]. Type 1 surface con-
tains intact synovial epithelium. Type 2 surface shows
loss of synovial epithelial cells without fibrin deposition.
In type 3 surface there is fibrin deposition and in type 4
surface there is extensive necrosis and loss of architec-
ture. The extent of type 4 surface necrosis was used to
grade the overall tissue necrosis in a given sample, as
described by Natu et al. [7]. In grade 4 necrosis, more
than 75% of the tissue sample showed type 4 surface
necrosis. In grade 3 necrosis, between 25 and 75%
showed type 4 surface necrosis. In grade 2 necrosis
either less than 25% of the tissue showed type 4 surface
necrosis or the tissue showed type 3 surface. In grade 1
necrosis, the sample consisted of type 2 surface.
Statistical analysis
Statistical analyses were performed using SPPS software
(IBM Corp. Released 2012. IBM SPSS Statistics for
Windows, Version 21.0. Armonk, NY: IBM Corp.).
Medians, ranges and interquartile ranges were calcu-
lated for total wear volume in both hips (skewed distri-
bution). The statistical significance of the difference in
wear volume between the higher and lower wearing side
Table 1 Reasons for revision surgery
Reasons for revision surgery
Progressively elevating whole blood metal ion levels 22 hips (38%)
Symptomatic hip and elevated whole blood metal ion levels 14 hips (24%)
Symptomatic hip, not elevated whole blood metal ion levels 5 hips (9%)
Pseudotumor and elevated whole blood metal ion levels 14 hips (24%)
Aseptic cup loosening 3 hips (5%)
Total 58 hips (100%)
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was tested using Wilcoxon signed ranks test (related sam-
ples). Mann-Whitney U-test was used to test the difference
in wear volume distribution between the hips in patients
with symmetric versus asymmetric histological and imaging
findings (independent samples). The differences in histo-
logical findings between left and right hips were compared
and number of patients with identical findings, patients
with a difference of one point, difference of two points be-
tween the sides etc. calculated. The statistical significance
of the difference in histological findings between the sides
was tested with marginal homogeneity test except the dif-
ference in presence of germinal centers which did not fill
the test requirements and McNemar test was used instead
[38]. Whether presence of MRI-confirmed pseudotumour
was similar between left and right sides was tested using
McNemar test (related samples).
Results
Thirteen of the 29 patients included in the study were
females (45%). Mean age of the patients was 61.7 years
(SD 8.3 years) at the time of the first revision operation
and 63.1 years (SD 8.5 years) at the time of the second
revision operation, respectively. On average, the first hip
was revised 4.5 years (SD 1.29 years) and the second hip
5.8 years (SD 1.8 years) after the primary operation.
Component wear was available bilaterally for 17 (59% of
all) patients. Total wear volume in either hip ranged from
3mm3 to 94mm3 (median 13mm3, IQR 10 to 32mm3).
The median difference in wear volume between higher
and lower wearing side was 15.35 mm3 (range 1 to
39 mm3, IQR 6 to 23 mm3) (p < 0,001). This difference
is illustrated in Fig. 1. The median ratio of total wear
volume between the hips was 2.0 (range 1.09 to 10.0,
IQR 1.67 to 3.72). In 9 of the 17 (53%) patients with
wear data available, the ratio of wear was 2.0 or
greater, ie. there was at least two-fold difference in
the wear volume between the hips.
The variability of histological findings was high
(Table 2). Most hips evinced mild-to moderate macro-
phage and lymphocyte infiltration, while in some pa-
tients there was heavy infiltration of either macrophages
or lymphocytes but not both simultaneously. The degree
of necrosis was approximately evenly distributed in all
five grades. Majority of patients evinced no plasma cells,
diffuse lymphocytic infiltration, germinal centers or
granulomas.
The congruence of histological findings between the
left and the right hips is presented in Table 3. In major-
ity of the histological features and also in majority of the
patients, there were no differences between the hips
(p > 0.05 for all comparisons). These features included
macrophage sheet thickness, perivascular lymphocyte
cuff thickness, presence of plasma cells, presence of dif-
fuse lymphocytic infiltration and presence of germinal
centers. In lymphocyte cuff thickness the difference be-
tween the sides was at most 1 point. In macrophage
sheet thickness the findings were similar in 18 patients,
differed by 1 point in 9 patients and differed by 2 points
in 2 patients, respectively. The only histological findings
that statistically significantly differed between the hips
were grade of necrosis (p < 0.01) and presence of granu-
lomas (p = 0.025). In the grade of necrosis there was a
wide distribution in the difference between the sides. In
those patients with granuloma present on one side only,
the granuloma was always on the higher-wearing side.
When comparing all hips, those hips with a granuloma
(n = 5) had a median total wear volume of 35 mm3
(range 15.0 to 111.0) and those hips with no granuloma
(n = 39) had a median total wear volume of 15 mm3
(range 3.0 to 94.0) (p = 0.059 for comparison). In the
grade of necrosis, the higher grade was not always on
the higher wearing side. In any of the histological find-
ings, the symmetry or asymmetry of findings between
left and right sides was not associated with a difference
in the distribution of wear volume between the sides
(Table 4). All patients had at least two histological vari-
ables with similar findings on both hips. Majority of the
patients (75.9%) had four or more histological variables
with similar findings on both sides (Table 5). There were
no differences in the similarity or dissimilarity of histo-
logical findings between left and right hips in males ver-
sus females (Table 6).
Bilateral MRI classification for the presence of pseudo-
tumours was available for 25 patients (86% of all pa-
tients). 18 patients (72% of the classified) had either
bilateral pseudotumours or no pseudotumours at all on
either side, ie. the hips were symmetrical in regard to
pseudotumour. There was no statistically significant dif-
ference in the presence of pseudotumour between the
sides (p = 0.13). Of those 18 patients, 7 had pseudotu-
mour on both sides (of which two were identical by
exact classification) and 11 had no pseudotumour on ei-
ther side. Patients with asymmetrical pseudotumour
finding between the sides evinced similar distribution of
total wear volume between the sides as those patients
with symmetrical pseudotumour findings (Table 7). In
addition, there were no differences in the total wear vol-
umes of the hips in patients with pseudotumour on both
sides (median 20.0 mm3, range 9.0 to 111.0) versus no
pseudotumour on either side (median 16.30 mm3, range
3.0 to 51.0) (p = 0.28 for comparison).
Discussion
In the present study, we found that there were notable
differences in the histological findings between patients
revised for ARMD, ie. the between-subject variability
was high. Heterogeneity has been characteristic for the
results of ARMD research [16]. Most importantly,
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however, we found no statistically or clinically significant
differences in most of the histological and imaging find-
ings between left and right hips of the same patient,
meaning that the within-subject variability in histological
and imaging findings was low. Further, majority of the
patients had similar findings on both hips in several key
histological variables. This was despite the fact that there
was a clinically and statistically significant difference in
the amount of wear volume between the sides, ie. there
was a difference in the extrinsic factor between the sides.
There are no clearly defined boundaries for abnormal
versus normal wear, but volumetric wear rates exceeding
1 mm3/year are generally considered abnormal [39]. As
the median difference of 15.4 mm3 in wear volume be-
tween the sides measured in our study translates into re-
markably abnormal yearly volumetric wear rate needed
to generate that difference, we thus feel safe to consider
the difference in median wear volume between the sides
clinically significant.
The contribution of host-specific factors in the patho-
genesis of ARMD has been suggested in numerous pre-
vious studies, likely observed as patient susceptibility of
different levels [8, 13, 14, 24–28]. However, to the best
of our knowledge there are no previous studies that
would have actually assessed the role of intrinsic factors
in the pathogenesis. On the contrary, there are many
studies that have investigated implant wear and the
development of ARMD, however, results of these studies
are very discrepant. High wear or high blood metal ion
levels resulting from high wear are associated with the
development of ARMD [10, 40]. However, adverse reac-
tions have been noted in patients with both high and
low wearing hip implants [8, 11, 13, 25, 41]. In a system-
atic review by Campbell et al. no clear dose-response
relationship between wear and ARMD could be estab-
lished [16]. We observed symmetry of histological find-
ings between left and right hips despite differing
amounts of wear. In addition, the distribution of wear
volume between the sides was similar in patients with
symmetrical versus asymmetrical histological and im-
aging findings. Further, patients with bilateral pseudotu-
mours had similar amounts of wear volumes in their
hips as did patients with no pseudotumour on either
side. Our finding suggests that there are intrinsic factors
that markedly contribute to the pathogenesis of ARMD,
dictating the type of tissue response and development of
pseudotumours, in addition to extrinsic factors such as
volume of the metal wear debris. Further, it is likely that
there are differences in these intrinsic factors between
patients as some develop aggressive tissue responses
despite low-wearing implant while some tolerate large
amounts of wear. Various terms have been used to
Fig. 1 The difference in total wear volume between higher and lower wearing sides
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describe this phenomenon, for example patient suscepti-
bility [13]. Clinicians should bear in mind that some pa-
tients with low wearing implants (low blood metal ion
levels) can still be at risk for ARMD due to higher than
average patient susceptibility.
A cohort of patients with bilateral MoM hips forms an
excellent research frame to investigate and compare the
role of intrinsic and extrinsic factors in the pathogenesis.
We are aware of only three previous studies that com-
pare characteristics of ARMD between the sides in pa-
tients with bilateral MoM hip replacements. Madanat et
al. compared MRI findings between left and right hips in
patients with bilateral MoM hip replacements [42]. They
found that the soft tissue reaction observed in MRI was
symmetrical between the sides in most patients, both in
sequentially and simultaneously implanted hips. In sup-
port of their findings, we report similar symmetry for
the presence of MRI-confirmed pseudotumour between
the sides. Another study by Pandit et al. consisted of
four revised patients with bilateral MoM hips [43]. All
patients had developed a necrotic pseudotumor in both
hips. In histopathological analysis, both hips of each
patient had similar findings (necrosis, macrophages,
lymphocytes). However, no wear data was included in
the study and the histology was descriptive, not semi-
quantitatively scored. A recent study by Uchihara et al.
included patients with both uni- and bilateral MoM
hips that had been revised for ARMD [44]. They com-
pared histological findings between left and right hips
in the bilateral patients as well as histological findings
between unilateral and bilateral patients. In addition,
time-to-failure was compared between these two
groups. The histological findings (necrosis, macro-
phages, lymphocytes) between left and right hips of the
bilateral patients were found to be symmetrical in ma-
jority of the cases, similar to the findings of the present
study. However, we observed that there were differ-
ences in the grade of necrosis between the sides while
Uchihara et al. did not semiquantitatively grade the ne-
crosis. Further, there were no differences in the histo-
logical findings or time-to-failure between uni- and
Table 3 Congruence in histological grading between left and right hips (within-subject)
Difference in histological grading between left and right sides
No difference 1 p 2p 3p 4p Scale
Macrophage sheet thickness 18 (62%) 9 (31%) 2 (7%) – 0–3 p
Lymphocyte cuff thickness 14 (48%) 15 (52%) – – 0–3 p
Degree of necrosis* 6 (21%) 10 (34%) 9 (31%) 1 (3%) 3 (10%) 0–4 p
Presence of plasma cells 26 (90%) 3 (10%) Yes/no
Presence of diffuse lymphocytic infiltration 19 (66%) 10 (34%) Yes/no
Presence of germinal centers 27 (93%) 2 (7%) Yes/no
Presence of granulomas* 24 (83%) 5 (17%) Yes/no
Percentages represent proportion of all patients. In variables marked with * there was a statistically significant (p < 0.05) difference between the sides (see results)
Table 2 Between-subject differences in histological findings
Histological finding Right hips Left hips
Macrophage sheet thickness
0 (absent) 1 (3.4%) 1 (3.4%)
1 (< 1 mm) 19 (65.5%) 24 (82.8%)
2 (1–2 mm) 7 (24.1%) 4 (13.8%)
3 (> 2 mm) 2 (6.9%) 0 (0.0%)
Lymphocyte cuff thickness
0 (absent) 13 (44.8%) 13 (44.8%)
1 (0.25 mm) 11 (37.9%) 11 (37.9%)
2 (0.25–0.75 mm) 5 (17.2%) 4 (13.8%)
3 (> 0.75 mm) 0 (0.0%) 1 (3.4%)
Degree of necrosis
0 6 (20.7%) 0 (0.0%)
1 4 (13.8%) 3 (10.3%)
2 8 (27.6%) 7 (24.1%)
3 7 (24.1%) 5 (17.2%)
4 4 (13.8%) 14 (48.3%)
Presence of plasma cells
No 23 (79.3%) 22 (75.9%)
Yes 6 (20.7%) 7 (24.1%)
Presence of diffuse lymphocytic infiltration
No 22 (75.9%) 20 (69.0%)
Yes 7 (24.1%) 9 (31.0%)
Presence of germinal centers
No 27 (93.1%) 29 (100%)
Yes 2 (6.9%) 0 (0.0%)
Presence of granulomas
No 23 (79.3%) 28 (96.6%)
Yes 6 (20.7%) 1 (3.4%)
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bilateral patients in their study. Uchihara et al. concluded
that the implantation of a MoM hip does not appear to
lead to sensitization to metal debris that would in turn
lead to poor clinical performance or different tissue re-
sponse in the second MoM hip. However, they did not
discuss the significance of their findings in the context of
intrinsic factors contributing to the similarity of the tissue
response between the hips in bilateral patients. Further,
their sample size was rather small (10 patients) and no
wear data of the MoM hips was presented in the study.
These three previous studies conducted on bilateral MoM
patients are in agreement with our findings and support
the hypothesis of an individual host response dictated by
intrinsic factors as a significant contributor in the
development of soft tissue reactions leading to failure of
the hip.
The pathogenesis of ARMD is poorly understood, but
at least three different mechanisms of failure have been
suggested: 1) type IV hypersensitivity response to metal
wear debris with adaptive immunity involvement, 2)
foreign-body response to metal wear particles reflecting
innate immunity and 3) direct cytotoxic effect of metal
ions [6, 8, 45]. To what degree the tissue response de-
pends on the amount of wear and to what degree on the
host-specific intrinsic factors is not well understood. We
hypothesized that components of the innate response
(macrophages, granulomas, necrosis) are more closely
related to extrinsic factors and components of the adap-
tive response (lymphocytes, germinal centers and plasma
cells) to intrinsic factors such as genetic predisposition
to metal hypersensitivity. We found that the grade of
tissue necrosis and presence of granulomas differed
between the sides in most patients. Granulomas were
always present on the higher wearing side. Further, when
analyzing all hips as a group, we found that there was a
trend for higher total wear volume in hips with a granu-
loma compared to those hips with no granuloma. How-
ever, this difference did not quite reach statistical
significance. Granulomas are considered to form as a re-
sponse to high numbers of metal particles in tissues
[46]. Our results support this idea. Still, in the present
study granulomas were not present in the majority of
the hips. We suggest that there is a certain threshold for
tissue metal content needed for granulomas to develop
as a response. Whether this threshold is dependent on
intrinsic factors, particle size, non-particulate metal deb-
ris or particle type is not understood and requires fur-
ther research. The metal ions released from implants are
known to cause dose-dependent cytotoxicity in-vitro
[47]. Also, we and others have previously shown that im-
plant wear correlates with necrosis of the periprosthetic
tissues [6, 48]. Thus, it seems likely that extrinsic factors,
mainly implant wear, are more important in the develop-
ment of tissue necrosis and granulomas than intrinsic
factors, ie. patient susceptibility. However, opposite to
our hypothesis, the grade of macrophage sheet thickness
did not differ between the sides. This would suggest that
the macrophage response (innate) is mostly determined
by host-specific factors instead of extrinsic factors such
as volume of the wear debris. However, there are limita-
tions in our methodology. We did not directly measure
the number of macrophages, instead, we measured the
thickness of the macrophage sheets. It is possible that
the infiltration penetrates deep in the tissue but is not
dense. We observed that there were no statistically sig-
nificant differences in the amounts of lymphocytes and
presence of plasma cells and germinal centers between
the hips, despite markedly different wear volumes in
most of these patients. These parameters belong to the
adaptive immune system which is considered host-specific.
Thus, it makes sense that they are expressed symmetrically.
In some studies, it has been found that low wear is
associated to adaptive lymphocytic response and high
wear to innate, macrophage dominated foreign-body
response [6, 8, 21]. These associations have been weak,
however. In addition, disagreeing findings have been
Table 5 The degree of similarity between the hips measured by
the number of histological variables with similar findings on
both sides in each patient
Histological variables with
symmetric findings on both sides
Number of
patients
Percentage of
patients
0 0 0%
1 0 0%
2 2 6.9%
3 5 17.2%
4 6 20.7%
5 6 20.7%
6 9 31.0%
7 1 3.4%
Total 29 Total 100%
Table 4 Median differences in total wear volumes between the
sides (mm3)
Histology between sides Symmetrical Asymmetrical P-value
Macrophages 9.0 18.7 0.40
Lymphocytes 18.0 12.7 0.89
Necrosis 32.0 12.7 0.35
Plasma cells 16.0 5.3 0.24
Diffuse lymphocytes 16.0 6.3 0.48
Germinal centers 15.7 23.0 0.71
Granulomas 15.35 16.1 0.70
Median differences in total wear volumes between the sides in patients with
symmetrical histological findings versus patients with asymmetrical histological
findings. Only patients with complete wear data are included (n = 17)
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published [19, 22]. We suggest that host-specificity of
the intrinsic factors leads to differences in the tissue
response between individuals no matter what the wear.
This likely contributes to the poor association between
the amount of wear and type of inflammatory tissue
response in previous literature.
Our study is not without limitations. First, the sample
size in our study is rather small. However, it is clearly
the largest in any published study dealing with this issue
so far. Second, not all hips were analyzed for bearing
wear volume. However, it must be noted that large pa-
tient cohorts with clinical information, laboratory and
imaging findings, tissue samples and also retrieval ana-
lyses available, are not easily available anywhere globally.
Further, our patient cohort is free of selection bias as all
patients have been primarily operated and followed-up
thereafter at our institution with no referrals from other
centers. Thirdly, we were not able to analyze the volume
of the material loss from the trunnion in those patients
with ASR XL hip implants. However, the volume of the
material loss from the trunnion is known to be less than
that from the bearing couple [49]. Fourth, we used surro-
gate markers (semiquantitative histology) to indirectly in-
vestigate the presence of intrinsic factors contributing to
the response. Measuring variability in signaling pathways
provide more direct evidence, but was out of the scope of
the current study. Besides, histological methods are
well-documented and there is vast amount of literature
regarding ARMD histology. However, it is not yet well
understood which signaling pathways are important in the
development of ARMD and thus a comprehensive study
of such would not be realistic. Our study offers novel
insight into the role of intrinsic versus extrinsic factors in
the pathogenesis of ARMD and is the largest bilateral
patient cohort published on the subject. Further, our study
is the first one to include wear data.
Conclusion
In conclusion, intrinsic host-specific factors most likely con-
tribute to the development of ARMD in addition to extrinsic
factors such as implant wear debris. Further, it is likely that
there are differences in these host-specific factors between pa-
tients, manifesting as susceptibility to metal debris of variable
degree. Clinicians should bear in mind that patients may have
different responses to the same amount of wear debris, usu-
ally measured as blood metal ion levels. Some patients may
tolerate high amounts of metal debris and some patients may
develop even severe adverse tissue responses in the presence
of a low-wearing hip implant. Also, bilateral MoM patients
with failure on one side will likely develop a similar tissue re-
sponse on the other side as well. This should be accounted
for in the follow-up of patients with bilateral MoM hip re-
placements. In future studies, it is important to search for
possible biomarkers that would predict the severity and type
of the intrinsic response, in other words, patient susceptibility.
Further, it is important to understand the true nature of
ARMD in order to be able to design safer bearing couples in
the future.
Table 7 Pseudotumour finding and wear volumes between the
sides
Pseudotumour Symmetrical Asymmetrical P-value
Median difference in total wear
volume between the sides (mm3)
12.7 13.5 0.79
The distribution of wear volume between left and right sides is similar in
patients with symmetrical and asymmetrical pseudotumour findings between
the sides. Only patients with complete wear data are included (n = 17)
Table 6 Comparison of similar versus not similar histological findings between the sides in males and females
Histological variable Symmetric findings on both hips Males Females P-value for the difference
between males and females
Macrophage sheet thickness Yes 11 (69%) 7 (54%) 0.46
No 5 (31%) 6 (46%)
Lymphocytic cuff thickness Yes 9 (56%) 5 (38%) 0.46
No 7 (44%) 8 (62%)
Degree of necrosis Yes 4 (25%) 2 (15%) 0.66
No 12 (75%) 11 (85%)
Presence of plasma cells Yes 14 (88%) 12 (92%) 0.58
No 2 (12%) 1 (8%)
Presence of diffuse lymph. Yes 12 (75%) 7 (54%) 0.27
No 4 (25%) 6 (46%)
Presence of germinal centers Yes 15 (94%) 12 (92%) 1.0
No 1 (6%) 1 (8%)
Presence of granulomas Yes 15 (94%) 9 (69%) 0.14
No 1 (6%) 4 (31%)
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